All Pharmaceutical industry articles – Page 7
View all stories with this category.
-
BusinessNovartis’ $8.7bn AveXis deal shows gene therapy appeal
Acquisition indicates the value of potentially permanent cures for inherited diseases
-
-
Research
Solving the crystal maze
Workflow swaps gut feelings for data when designing continuous crystallisation processes
-
Business
Fit for repurpose
Drugs that can be used for new indications offer a potentially cheaper pathway – but only if the investors can recoup their costs
-
Feature
Cuba: socialism, cigars and biotech
Nina Notman learns how biotechnology could potentially overtake cigars as Cuba’s most famous export
-
News
Brexit analysis predicts chemical industry contraction
UK government forced to publish briefing that suggests production will fall by up to 16%
-
Sponsored
Pharma and academia: a recipe for success
More big pharmaceutical companies are collaborating with universities
-
News
English health service could recover £500m in drug costs from Pfizer
NHS England may have paid over the odds for pain drug whose patent has now been revoked
-
Business
Indian court seizes former Ranbaxy owners’ assets
Daiichi Sankyo inches closer to recovering money from Singh brothers
-
Business
Chemist caught stealing and dumping cyanide
Merck & Co senior analytical chemist arrested for stealing and then dumping highly toxic substance down a curbside drain
-
Business
BMS stimulates cancer drug hopes with giant collaboration
Immunooncology pioneer will pay up to $3.6bn in hope Nektar drug will help non-responders
-
News
Illegal antibiotic combinations threaten efforts to battle antimicrobial resistance
Unapproved formulations make up two-thirds of combination therapies sold in India
-
Business
Sanofi enters M&A bonanza
French drugmaker strengthens rare diseases portfolio with blood disorder purchases
-
News
Apotex chief executive steps down amid tumult at generics firm
President and chief executive of Canada’s biggest generic drugmaker resigns the same day that police announce its founder and his wife were murdered
-
Opinion
Why modern chemists need to think big
The lessons we can learn from the larger reaction scales of the past
-
Business
Celgene takes a punt on M&A
Cancer specialist bags Juno therapeutics and Impact Biomedicines
-
Business
FDA new drug approvals more than doubled in 2017
The FDA approved 46 new drugs last year – the highest number in over two decades – due to factors like streamlined policies at the agency
-
Research
1500 reactions per day go with the flow
Automated flow chemistry system puts high-speed spin on drug discovery
-
Business
Non-profit generic drug company created
Intermountain Healthcare is leading an effort in the US to prevent drug shortages and end their skyrocketing prices
-
News
UK drug discovery model must ‘break and change’
Report calls for joined-up approach that brings together charities, industry and universities
